Ikena Oncology, Inc.IKNANASDAQ
Loading
Free Cash Flow Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+206.6%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
+206.6%/yr
Quarterly compound
Percentile
P100
Near historical high
vs 3Y Ago
28.8x
Strong expansion
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 72.91% |
| Q3 2025 | -678.55% |
| Q2 2025 | 67.60% |
| Q1 2025 | -68.72% |
| Q4 2024 | 29.96% |
| Q3 2024 | 28.51% |
| Q2 2024 | 31.70% |
| Q1 2024 | 17.11% |
| Q4 2023 | -10.42% |
| Q3 2023 | -10.19% |
| Q2 2023 | 8.97% |
| Q1 2023 | -11.46% |
| Q4 2022 | 2.53% |
| Q3 2022 | 5.83% |
| Q2 2022 | 1.67% |
| Q1 2022 | -42.38% |
| Q4 2021 | 23.42% |
| Q3 2021 | -14.22% |
| Q2 2021 | -13.58% |
| Q1 2021 | -5.97% |
| Q4 2020 | -72.36% |
| Q3 2020 | 0.53% |
| Q2 2020 | 22.82% |
| Q1 2020 | -22.17% |
| Q4 2019 | 0.00% |